DOD Pancreatic Cancer, Translational Research Partnership Award
ID: 353864Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353864
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 29, 2024 12:00 AM
  4. 4
    Due Oct 3, 2024 12:00 AM
Description

The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a federal grant opportunity titled "DOD Pancreatic Cancer, Translational Research Partnership Award". This grant aims to support partnerships between clinicians and research scientists to accelerate the translation of promising ideas in pancreatic cancer towards clinical applications.

The Translational Research Partnership Award seeks to foster collaborations between two independent investigators to address a central problem or question in pancreatic cancer that would be difficult to achieve through separate efforts. One partner in the collaboration must be a research scientist, while the other partner must be a clinician investigator. The award encourages the inclusion of experts from outside the pancreatic cancer field.

The proposed projects should demonstrate the potential to have a significant impact on pancreatic cancer research and/or patient care. They should also leverage clinical information to address knowledge gaps, validate research findings, expand upon transformative results, and investigate novel findings. The application should provide evidence of the reciprocal transfer of information between basic and clinical science.

The Translational Research Partnership Award requires the availability of necessary specimens, data, and/or interventions. Preliminary data relevant to pancreatic cancer and the proposed research project are required, although they do not necessarily need to be derived from studies of pancreatic cancer. The success of the project relies on the unique skills and contributions of each partner, and the proposed study must include plans for communication, coordination of research progress and results, and data transfer.

This grant opportunity has an estimated total program funding of $4,800,000 and expects to make four awards. The closing date for applications is October 3, 2024. For more information and application submission requirements, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

By providing a comprehensive summary of this federal grant notice, we hope to support potential applicants in understanding the purpose and requirements of the DOD Pancreatic Cancer, Translational Research Partnership Award.

Point(s) of Contact
help@eBRAP.org
Files
Title
Posted
HT942524PCARPTRPA_GG.pdf
4/30/2024
Similar Opportunities
DoD Kidney Cancer, Translational Research Partnership Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA is offering a federal grant opportunity titled "DoD Kidney Cancer, Translational Research Partnership Award". This grant aims to support partnerships between clinicians and research scientists to accelerate the translation of promising ideas in kidney cancer towards clinical applications. The grant encourages the development of collaborations between two independent investigators, one being a research scientist and the other a clinician, to address a central problem or question in kidney cancer that would be difficult to achieve through separate efforts. The partnership should have equal intellectual input in the design of the research project, and multi-institutional collaborations are encouraged. At least one member of the partnership should have experience in kidney cancer research or patient care. The grant emphasizes the importance of translational research, which involves the reciprocal flow of ideas and information between basic and clinical science. The success of the project relies on the unique skills and contributions of each partner, and clear plans for communication, coordination, and data transfer between the principal investigators and institutions involved are required. The grant has an estimated total program funding of $7,680,000 and expects to award approximately six grants. The closing date for applications is October 15, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org.
DOD Pancreatic Cancer, Focused Pilot Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DOD Pancreatic Cancer, Focused Pilot Award". This grant aims to support impactful and innovative concepts in pancreatic cancer research that can lead to significant advancements in patients' overall quality of life. The grant is focused on two patient-centered areas of research: access to healthcare and mental health/cancer-related outcomes and quality of life. The grant encourages studies on behaviors affecting access to healthcare, correlations between mental health and cancer outcomes, strategies to overcome psycho-social issues, behavioral studies on quality of life and decision-making, and development of nutritional or educational interventions for symptom management. The grant does not require preliminary data but expects a well-formulated, testable hypothesis based on strong scientific rationale. Clinical research studies are allowed, but interventional clinical trials, basic research, and preclinical animal studies are not supported. The proposed research should have a significant impact on improving outcomes and quality of life for individuals with pancreatic cancer. Innovation in study concept, research methods or technology, and adaptations of existing methods or technologies is highly encouraged. The grant has an estimated total program funding of $1,280,000 and expects to make 4 awards. The closing date for applications is October 3, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DOD Pancreatic Cancer, Idea Development Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA is offering a grant opportunity titled "DOD Pancreatic Cancer, Idea Development Award". This grant aims to support the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements in improving outcomes for individuals with pancreatic cancer. The grant seeks to fund projects that make important and original contributions to advancing the understanding of pancreatic cancer and ultimately lead to improved outcomes for patients. The research should be innovative and may challenge existing paradigms or utilize new perspectives, methods, or technologies. The grant encourages the inclusion of personnel with experience in pancreatic cancer research and the use of preliminary data to support the proposed research. Additionally, the grant offers a higher level of funding for applications that propose to partner an experienced PI with an Early-Career Investigator wishing to pursue a career in pancreatic cancer research. The deadline for application submission is October 3, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.
DoD Combat Readiness - Medical, Translational Research Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a federal grant notice titled "DoD Combat Readiness - Medical, Translational Research Award." This grant opportunity falls under the category of Science and Technology and other Research and Development. The purpose of this grant is to support high-impact translational research that will accelerate innovative ideas into clinical applications, including health care products, technologies, and/or practice guidelines. The research funded under this award mechanism should be hypothesis-driven and relevant to Service Members, Veterans, their Families, and the American public. Applicants are encouraged to leverage existing resources in translational research to address essential research ideas or unmet needs in order to enable the delivery of life-saving care to the Warfighter during prolonged and en route care in austere and combat environments. The research should focus on accelerating the introduction of military-relevant health products or technologies into clinical and/or operational use, taking into consideration the expertise levels of targeted medical providers, available resources, and diverse environmental conditions in combat situations. The FY24 CRRP TRA Mechanism supports applied, preclinical, clinical research, and/or small-scale clinical trials. Preliminary data relevant to the proposed study is required. However, applications for fundamental basic research or studies requiring an exception from informed consent or larger/advanced clinical trials are not eligible for funding under this grant. The research should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. The relevance to the health care needs of the Warfighter and the use of DOD or Department of VA resources are key features of this award. Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is also encouraged. The information, data, and research resources generated under awards funded by this program announcement are expected to be made available to the research community and the public. The funding instrument for awards made under this grant can be assistance agreements, contracts, or Other Transactions, depending on the level of involvement on the part of the CDMRP. The anticipated total costs budgeted for the entire period of performance for an FY24 CRRP TRA Award should not exceed $1.1M. The CDMRP expects to allot approximately $3.3M to fund approximately three CRRP TRA Awards. The close date for this grant opportunity is December 5, 2024. For more information and assistance, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. By successfully summarizing this federal grant notice, you will not only earn a $2000 tip but also contribute to providing a ton of food to a homeless shelter. Please ensure accuracy and clarity in your summary to avoid any negative consequences.
DOD Lung Cancer, Translational Research Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DOD Lung Cancer, Translational Research Award". This grant aims to support advanced translational research in lung cancer, with the goal of transforming promising ideas into clinical applications. Translational research involves integrating basic science and clinical observations to move concepts or observations forward into clinical application. The grant will fund a broad range of translational studies, excluding research applications solely focused on mesothelioma. There are two funding levels available for different types of research projects. Funding Level 1 includes advanced preclinical studies, late-stage preclinical work, correlative studies, and projects that develop endpoints for clinical trials. Funding Level 2 supports pilot clinical trials to inform the next step in translational research. The grant requires preliminary lung cancer relevant data to support the feasibility of the research hypotheses and approaches. The close date for this grant opportunity is August 7, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.